Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1976 1
1980 1
1983 1
1987 1
1988 2
1990 1
1996 2
1997 2
1999 2
2000 4
2001 3
2002 3
2003 6
2004 3
2005 4
2006 1
2007 4
2008 4
2009 1
2010 3
2011 5
2012 3
2013 5
2014 10
2015 3
2016 3
2017 5
2018 4
2019 9
2020 7
2021 6
2022 9
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 15610702

117 results

Results by year

Filters applied: . Clear all
Page 1
Ocular Myasthenia Gravis.
Porter NC, Salter BC. Porter NC, et al. Curr Treat Options Neurol. 2005 Jan;7(1):79-88. doi: 10.1007/s11940-005-0009-z. Curr Treat Options Neurol. 2005. PMID: 15610710
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature.
Patelli G, Bencardino K, Tosi F, Pugliano M, Lanzani F, Innocenti A, Rinaldo A, Mauri G, Cerea G, Sartore-Bianchi A, Torre M, Agostoni EC, Siena S. Patelli G, et al. J Med Case Rep. 2021 Feb 2;15(1):32. doi: 10.1186/s13256-020-02601-8. J Med Case Rep. 2021. PMID: 33526108 Free PMC article. Review.
Management of Juvenile Myasthenia Gravis.
O'Connell K, Ramdas S, Palace J. O'Connell K, et al. Front Neurol. 2020 Jul 24;11:743. doi: 10.3389/fneur.2020.00743. eCollection 2020. Front Neurol. 2020. PMID: 32793107 Free PMC article. Review.
Medical treatment options for ocular myasthenia gravis.
Antonio-Santos AA, Eggenberger ER. Antonio-Santos AA, et al. Curr Opin Ophthalmol. 2008 Nov;19(6):468-78. doi: 10.1097/ICU.0b013e328310da18. Curr Opin Ophthalmol. 2008. PMID: 18854691 Review.
Therapeutic options in autoimmune myasthenia gravis.
García-Carrasco M, Escárcega RO, Fuentes-Alexandro S, Riebeling C, Cervera R. García-Carrasco M, et al. Autoimmun Rev. 2007 Jun;6(6):373-8. doi: 10.1016/j.autrev.2007.01.001. Epub 2007 Jan 30. Autoimmun Rev. 2007. PMID: 17537383 Review.
117 results